Literature DB >> 11475838

Acute loss of capture due to flecainide acetate.

D Antonelli1, N A Freedberg, T Rosenfeld.   

Abstract

Antiarrhythmic drugs increase pacing threshold, but this is rarely of clinical significance. Administration of flecainide acetate in a 75-year-old woman with an implanted AAIR pacemaker because of sick sinus syndrome caused an abrupt rise of pacing threshold and failure of pacing. Pacing threshold returned to the normal value a few days after flecainide treatment was stopped.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11475838     DOI： 10.1046/j.1460-9592.2001.01170.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN： 0147-8389            Impact factor:   1.976


  5 in total

1.  Atrial pacing failure following termination of atrial fibrillation by acute administration of disopyramide phosphate.

Authors:  Ryuko Anzawa; Shin-Ichiro Ishikawa; Yasuyuki Tanaka; Fumiko Okazaki; Seibu Mochizuki
Journal:  J Interv Card Electrophysiol       Date:  2005-06       Impact factor: 1.900

2.  Effectiveness of ibutilide in cardioversion of persistent atrial fibrillation in patients with dual chamber stimulation.

Authors:  Massimo Santini; Carlo Pignalberi; Renato Ricci; Leonardo Calò; Luca Santini
Journal:  J Interv Card Electrophysiol       Date:  2003-08       Impact factor: 1.900

3.  Antiarrhythmic Drug Therapy to Avoid Implantable Cardioverter Defibrillator Shocks.

Authors:  Jaber Abboud; Joachim R Ehrlich
Journal:  Arrhythm Electrophysiol Rev       Date:  2016-08

4.  Effects of flecainide and quinidine on arrhythmogenic properties of Scn5a+/- murine hearts modelling the Brugada syndrome.

Authors:  Kate S Stokoe; Richard Balasubramaniam; Catharine A Goddard; William H Colledge; Andrew A Grace; Christopher L-H Huang
Journal:  J Physiol       Date:  2007-02-15       Impact factor: 5.182

5.  A case of acute ventricular capture threshold rise associated with flecainide acetate.

Authors:  Tae Soo Kang; Young Won Yoon; Sungha Park; Bum-Kee Hong; Dongsoo Kim; Hyuck Moon Kwon; Hyun-Seung Kim
Journal:  Yonsei Med J       Date:  2006-02-28       Impact factor: 2.759
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.